Cardiovascular health technology assessment: recommendations to improve the quality of evidence
The aim of this article is to review the role of Health Technology Assessment (HTA) organisations in appraising and recommending innovative cardiovascular technologies. We consider how bias impairs the quality of evidence from clinical trials involving cardiovascular healthcare technologies. Finally...
| Published in: | Open Heart |
|---|---|
| Main Authors: | , , |
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2019-05-01
|
| Online Access: | https://openheart.bmj.com/content/6/1/e000930.full |